Evaluation of multiple comparison correction procedures in drug assessment studies using LORETA maps

The identification of the brain regions involved in the neuropharmacological action is a potential procedure for drug development. These regions are commonly determined by the voxels showing significant statistical differences after comparing placebo-induced effects with drug-elicited effects. LORETA is an electroencephalography (EEG) source imaging technique frequently used to identify brain structures affected by the drug. The aim of the present study was to evaluate different methods for the correction of multiple comparisons in the LORETA maps. These methods which have been commonly used in neuroimaging and also simulated studies have been applied on a real case of pharmaco-EEG study where the effects of increasing benzodiazepine doses on the central nervous system measured by LORETA were investigated. Data consisted of EEG recordings obtained from nine volunteers who received single oral doses of alprazolam 0.25, 0.5, and 1 mg, and placebo in a randomized crossover double-blind design. The identification of active regions was highly dependent on the selected multiple test correction procedure. The combined criteria approach known as cluster mass was useful to reveal that increasing drug doses led to higher intensity and spread of the pharmacologically induced changes in intracerebral current density.

[1]  P. Nunez,et al.  Electric fields of the brain , 1981 .

[2]  Edward M. Cross,et al.  Use of the Binomial Theorem in Interpreting Results of Multiple Tests of Significance , 1982 .

[3]  Bernd Saletu,et al.  Artifact processing in topographic mapping of electroencephalographie activity in neuropsychopharmacology , 1992, Psychiatry Research: Neuroimaging.

[4]  Bernd Saletu,et al.  Topographic pharmaco‐EEG mapping of increasing doses of buspirone and its comparison with diazepam , 1994 .

[5]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[6]  Eric Moulines,et al.  A blind source separation technique using second-order statistics , 1997, IEEE Trans. Signal Process..

[7]  Thomas E. Nichols,et al.  Statistical limitations in functional neuroimaging. II. Signal detection and statistical inference. , 1999, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[8]  John Suckling,et al.  Global, voxel, and cluster tests, by theory and permutation, for a difference between two groups of structural MR images of the brain , 1999, IEEE Transactions on Medical Imaging.

[9]  Roberto D. Pascual-Marqui,et al.  Effect of the 5-HT1A partial agonist buspirone on regional brain electrical activity in man: a functional neuroimaging study using low-resolution electromagnetic tomography (LORETA) , 2000, Psychiatry Research: Neuroimaging.

[10]  R D Pascual-Marqui,et al.  Standardized low-resolution brain electromagnetic tomography (sLORETA): technical details. , 2002, Methods and findings in experimental and clinical pharmacology.

[11]  I. Johnsrude,et al.  The problem of functional localization in the human brain , 2002, Nature Reviews Neuroscience.

[12]  Thomas E. Nichols,et al.  Nonparametric permutation tests for functional neuroimaging: A primer with examples , 2002, Human brain mapping.

[13]  Thomas E. Nichols,et al.  Thresholding of Statistical Maps in Functional Neuroimaging Using the False Discovery Rate , 2002, NeuroImage.

[14]  Thomas E. Nichols,et al.  Controlling the familywise error rate in functional neuroimaging: a comparative review , 2003, Statistical methods in medical research.

[15]  E. Bullmore,et al.  Human pharmacological MRI. , 2004, Trends in pharmacological sciences.

[16]  Thomas E. Nichols,et al.  Combining voxel intensity and cluster extent with permutation test framework , 2004, NeuroImage.

[17]  P. Anderer,et al.  Effects of the South American Psychoactive Beverage Ayahuasca on Regional Brain Electrical Activity in Humans: A Functional Neuroimaging Study Using Low-Resolution Electromagnetic Tomography , 2004, Neuropsychobiology.

[18]  B. Saletu,et al.  EEG-tomographic studies with LORETA on vigilance differences between narcolepsy patients and controls and subsequent double-blind, placebo-controlled studies with modafinil , 2004, Journal of Neurology.

[19]  A. Massey,et al.  Effects of DHEA administration on episodic memory, cortisol and mood in healthy young men: a double-blind, placebo-controlled study , 2006, Psychopharmacology.

[20]  Bernd Saletu,et al.  EEG Topography and Tomography (LORETA) in the Classification and Evaluation of the Pharmacodynamics of Psychotropic Drugs , 2006, Clinical EEG and neuroscience.

[21]  G. Buzsáki.  Rhythms of the brain , 2006 .

[22]  Claudio Del Percio,et al.  Frontal white matter volume and delta EEG sources negatively correlate in awake subjects with mild cognitive impairment and Alzheimer's disease , 2006, Clinical Neurophysiology.

[23]  Brent R Logan,et al.  An evaluation of spatial thresholding techniques in fMRI analysis , 2008, Human brain mapping.

[24]  Steven C.R. Williams,et al.  Application of Pharmacological MRI to Preclinical Drug Discovery and Development , 2008 .

[25]  P. Anderer,et al.  Double‐blind, placebo‐controlled, multiple‐ascending‐dose study on the effects of ABIO‐08/01, a novel anxiolytic drug, on perception and cognition, utilizing event‐related potential mapping and low‐resolution brain electromagnetic tomography , 2008, Human psychopharmacology.

[26]  Miguel Angel Mañanas,et al.  A comparative study of automatic techniques for ocular artifact reduction in spontaneous EEG signals based on clinical target variables: A simulation case , 2008, Comput. Biol. Medicine.

[27]  Dietrich Lehmann,et al.  Rivastigmine effects on EEG spectra and three-dimensional LORETA functional imaging in Alzheimer’s disease , 2008, Psychopharmacology.

[28]  Pavel Mohr,et al.  LORETA Functional Imaging in Antipsychotic-Naive and Olanzapine-, Clozapine- and Risperidone-Treated Patients with Schizophrenia , 2008, Neuropsychobiology.

[29]  Miguel A Mañanas,et al.  Influence of ocular filtering in EEG data on the assessment of drug‐induced effects on the brain , 2009, Human brain mapping.

[30]  Michael Wolzt,et al.  Double-Blind, Placebo-Controlled, Multiple-Ascending-Dose Study on the Pharmacodynamics of ABIO-08/01, a New CNS Drug with Potential Anxiolytic Activity , 2009, Neuropsychobiology.